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Japanese encephalitis is caused by Japanese encephalitis viruses (JEV) with 
neurotropism. As one of the most important immune organ, spleen is directly 
involved in immune response against JEV. However, little research about JEV 
infection process in spleen has been reported. In this study, immunopathological 
changes in mouse spleen were analyzed every other day after subcutaneous 
injection of mice with JEV wild-type strain P3 by immunohistochemistry assay. 
Immunohistochemistry analysis demonstrated that the number of T lymphocytes 
was reduced from 0 to 3 DPI, increased from 3 to 7 DPI, and reduced again from 7 
to 10 DPI. In addition, neurological dysfunction appeared at 6 DPI. These results 
suggested that spleen of mice suffered incontrovertible damages in influence of JEV 
infection. It can also be deduced that the cellular immunity took the crucial part in 
the first phase of transient viremia against JEV. Moreover, immune response was 
activated after the immune-depressed period in the first phase of viremia and 
neurological dysfunction appeared when cellular immunity was activated. Taking 
together, our research showed distinct immunopathological changes in mice after 
JEV infection, which enriched our understanding of Japanese encephalitis 
immunopathogenesis. 
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INTRODUCTION 
 
Japanese encephalitis (JE) is an acute zoonotic 
infection caused by Japanese encephalitis viruses (JEV) 
with neurovirulence and can result in permanent 
neurological sequelae or death. JEV, a member of 
flaviviridae, has spread through a vast geographic area 
including India, China, Japan and virtually all of 
Southeast Asia (van den Hurk et al., 2009), and it has 
recently been isolated from previously non-affected areas, 
such as Australia (Hanna et al., 1996). Globally, 
approximately 50,000 cases of JEV infection are reported 
every year and about 10,000 cases result in death (World 
Health Organization, 2007). Meanwhile, it also has 
serious consequences in sows reproduction and death in 
piglets (Mengeling et al., 1993). 
As we know, there are usually two phases in course 
of the Japanese encephalitis. In general, when people or 
animals are bitten by mosquitoes carrying JEV, the virus 
may intrude into the skin with mosquito saliva, move 
through  the  lymphatic  vessels  or  capillaries  monocyte-  
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monocyte-macrophage system, breed in Langerhans cells, 
dendritic cells or lymph nodes, liver, and spleen, and lead 
to the formation of the first phase of transient viremia 
(Mackenzie et al., 2004). Once people or animals suffer 
immune deficiency, JEV can invade the bloodstream 
again after proliferation to form the second phase of 
viremia. In this phase, the virus reaches the central 
nervous system (CNS) through blood-brain barrier (BBB) 
via leukocytes (probably T lymphocytes), where JEV 
virions then bind to the endothelial surface of the CNS 
and are internalized by endocytosis (Ghosh and Basu, 
2009). After that, non-suppurative encephalitis occurs, 
and clinical manifestation is focal neurological deficits, 
generalized weakness and movement disorders. However, 
people or animals with well-developed immunity acquire 
the capacity to combat JEV and recover after the short-
term viremia with mild symptom or no symptom. 
As the biggest lymphoid organ, the residence of 
various kinds of immunocytes and the base to respond to 
blood-borne antigen and generate effector substance, 
spleen plays the irreplaceable role in immunity to 
endogenous or ectogenic pathogeny. T lymphocytes 
which account for about 40% of immunocytes in the 
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spleen combat with pathogen through cellular immunity. 
Although many researchers have been making their 
endeavor to explore how JEV break through the BBB and 
the mechanism of JEV addiction to neurons and gliocytes, 
few researchers have focused on spleen, and the first 
phase of transient viremia always has been ignored. 
Therefore, little is known regarding spleen pathological 
changes in the immune response during the whole viremia 
after JEV infection.  
It has been demonstrated that mice are the prevalent 
model in the study of flavivirus encephalitis (Kimura et 
al., 2010). Thus in this study, we focused on mouse spleen 
in the first phase and the second phase of viremia to 
explore the immunopathological response against JEV 
infection. 
 
MATERIALS AND METHODS 
 
Animal inoculation 
JEV wild-type strain P3 was propagated in suckling 
mice brains and titered in BHK-21 cells. Fifty four-week 
old female BALB/c mice were purchased from Wuhan 
Institute of Biologic Products (Hubei Province, China) 
and randomly divided into two groups (25 mice per 
group): challenge group and control group. Mice in 
challenge group were inoculated subcutaneously with 
100µl of Dulbecco's Modified Eagle Medium (DMEM) 
(high-sugar) containing 6.25×10
3 PFU of wild-type JEV 
P3. Mice in control group were inoculated subcutaneously 
with 100µl of DMEM without JEV. Three mice in both 
challenge group and control group were sacrificed every 
other day after inoculation, and spleen and brain were 
harvested. 
 
Perfusion fixation 
Perfusion fixation was done after clinical observation 
and anatomy observation. In perfusion fixation process, 
blood in the whole body was flushed with 5 ml PBS and 
then the body was fixed with 5ml 4% paraformaldehyde. 
Both PBS and 4% paraformaldehyde were injected to 
ventriculus sinister, and outflowed from atrium dextrum 
after systemic circulation. Before this operation, a small 
cut was carefully made by eye scissors on atrium dextrum 
for fluid outflow. PBS was injected firstly with perfusion 
speed of 20 ml/min. After liver and kidney became pallid, 
4% paraformaldehyde was changed and the perfusion 
speed was 10 ml/min until mouse tail became stiff. The 
remains were discarded after bio-safety disposal and the 
used apparatus also underwent bio-safety disposal. The 
whole perfusion fixation operation was carefully done in 
the P2 laboratory in State Key Laboratory of Agricultural 
Microbiology and all procedures involving animals were 
carried out in accordance with the Animal Protection 
Regulations of China. 
 
Histology and immunohistochemistry assay 
Transversely 3 mm long Caput lienis each of three 
spleen on each sampling day was cut. In the same way, 
front half of brain was cut transversely on eacg sampling 
day. All tissues were embedded in paraffin wax and 3 µm 
successive sections were made, stained with H & E and 
immunohistochemistry (IHC) was carried out. For IHC, 
slides were stained after deparaffinating and hydration. 
Antigen was retrieved in citrate buffer (PH 6.0) with 
microwave, and endogenous avidin and biotin were 
blocked with Avidin/Biotin Blocking Kit (Vector, SP-
2001). Rabbit polyclonal antibody CD3 (Chemicon) 
(dilution 1:200), GFAP (DakoCytomation) (dilution 
1:1000) and IBA (Wako) (dilution 1:500) were used as the 
primary antibodies. Goat or horse serum was used as 
blocking antigen and then slides were incubated in 4°C 
for 15-18h with primary antibodies. Afterward, 
biotinylated secondary antibodies were incubated in 37°C 
for 30 min. Avidin and biotinylated alkaline phosphatases 
macromolecular complex (ABC) reagent was added and 
incubated for 20 min at 37°C. Goat or horse serum block 
liquid, second antibody and ABC reagent came from 
ABC-AP kit (Vector) or ABC kit (Vector). Finally, 
visualization was achieved by using Blue Alkaline 
Phosphatase Substrate Kit III (Vector) or DAB kit 
(Vector). Sections were counterstained with fast red or 
hematoxylin according to the need.  
Sections were analyzed by the application of Zeiss 
microscope and accompanying software (Zeiss). 
Quantitative analyses of T lymphocytes were performed 
by optical density value (OD value) through analyzing the 
grayscale in positive region on IHC sections with Image-
Pro Plus. There were three samples on each sampling day 
in both challenge group and control group, and at least 
three sections were made in each sample. Furthermore, 
pictures were collected under the same conditions and 
analyzed in the same camera shooting environment. 
 
Statistics analysis 
Variance was analyzed with two specimens. 
Statistical analysis was performed using the student t-test 
considering significant difference at P<0.05 and P<0.01.  
 
RESULTS 
 
Neurological dysfunction  
From 3 to 5 days post infection (DPI), mice in 
challenge group showed depressed spirit and piloerection. 
At 6 DPI, mice in challenge group began to suffer 
hypokinesia, sluggish, frequent blinking, lethargy, and 
clustering, suggesting the neurological dysfunction of 
infected mice. Some mice lost weight and became 
unresponsive and stiff, and some of them were led to 
death. Four, 6, 4, and 2 mice died respectively at 7, 8, 9, 
and 10 DPI. Liquid feces adhesion was found on the 
buttocks of the two dying mice at 10 DPI. There was no 
death after 11 DPI, and the survival mice turned to be 
normal after 11 DPI. Control group showed no symptoms 
and no death (Fig. 1). 
 
Congestion and hemorrhages on cranial arachnoid 
Cranial arachnoid of mice in challenge group showed 
congestion and hemorrhage. The liver of one mouse 
which died at 10 DPI turned black. Pathological changes 
from 0 to 10 DPI became severer with age. However, no 
lesion was found in other organs and mice in control 
group had no pathological changes.  
 
Non-suppurative encephalitis 
During 8 to 10 DPI, obvious non-suppurative 
encephalitis was observed in brains of mice in the Pak Vet J, 2011, 31(4): 299-304. 
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challenge group. Necrosis and even acute liquefaction 
necrosis was seen in some neurons. It was also found that 
glial nodule appeared near the vessel (Fig. 2B). Moreover, 
gliocytes and microglia cells were activated in the 
challenge group. Astrocytes were also activated and 
interwove with each other. However, no pathological 
changes appeared in the control group (Fig. 2A & 2C). 
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Fig. 1: Neurological dysfunction after JEV infection. 0=no 
depressed spirit, no piloerection, no frequent blinking, no 
movement disorder, no swelling eyelid; 1=depressed spirit, no 
piloerection, no frequent blinking, no movement disorder, no 
swelling eyelid; 2=depressed spirit, piloerection, no frequent 
blinking, no movement disorder, no swelling eyelid; 
3=depressed spirit, piloerection, frequent blinking, no 
movement disorder, no swelling eyelid; 4=depressed spirit, 
piloerection, frequent blinking, movement disorder, no swelling 
eyelid; 5=depressed spirit, piloerection, frequent blinking, 
movement disorder, swelling eyelid. 
 
T lymphocytes decreased from 0 to 3 DPI, increased 
from 3 to7 DPI and decreased again from 7 to 10 DPI  
T lymphocytes were primly distributed around 
periarterial lymphatic sheath (PALS) in mice of both the 
challenge and the control groups, just as the regular 
distribution of T lymphocytes (Fig. 3). Trends of T 
lymphocytes number were analyzed by detecting the 
average OD value of CD3 positive area (Fig. 4). 
Compared with the control group, T lymphocytes 
decreased during the first three days post-infection in the 
challenge group, but the difference between these two 
groups was not significant. Subsequently, T lymphocytes 
gradually increased from 3 to 7 DPI, while the difference 
was also not remarkable. From 7 to 10 DPI, T 
lymphocytes decreased again with the significant 
difference compared to control group (P<0.01) (Fig. 4).  
 
DISCUSSION 
 
Since spleen is the biggest lymphoid organ which 
plays the crucial role in immunity to endogenous or 
ectogenic pathogeny, investigating immunopathological 
changes of host spleen with viral infection may be helpful 
for understanding the mechanism of JEV pathogenesis. 
Our study showed that neurological symptoms in JEV-
infected mice appeared at 6 DPI, and T lymphocytes 
increased from 3 to 7 DPI and decreased in the next three 
days. It suggests that cellular immunity takes the crucial 
part in the first phase of viremia against JEV. 
The increase of T lymphocytes in the first phase of 
viremia from 3 to 5 DPI before BBB break may provide 
significant protection against JEV replication. It has been 
demonstrated that CD4
+ T lymphocytes can inhibit the 
proliferation of JEV (Diagana et al., 2007). Moreover, the 
cellular immune response seemed to contribute to the 
repression of JE during acute infection by restricting viral 
replication before the CNS is invaded (Misra and Kalita, 
2010). Therefore, the increase of splenic T lymphocytes in 
the first phase of viremia is an attempt to eliminate the 
virus. If so, the JEV entrance into brain will be inhibited 
and no neurological symptom will occur. However, 
cellular immunity has both positive and negative impact 
in the fight against JEV. Cytotoxic T lymphocytes rose 
rapidly to play a protective role to increase viral 
clearance. Whereas, the robust T lymphocyte response can 
be damaging to the host (Fujii et al., 2008) for it initiated 
an irreversible cellular immune activation leading to cell 
death. Mice lacking functional CD8+ T lymphocytes, or 
mice depleted of CD8+ T lymphocytes, show increased 
mortality, but survive longer than wild-type mice with low 
dose of WNV, indicating that CD8+ T lymphocytes have 
both protective and immunopathological effect (King et 
al., 2007). Unluckily, in this study, T lymphocytes 
increase failed to restrain JEV proliferation in this young 
mice model as most of the mice showed neurological 
symptoms. The robust T lymphocyte response from 3 to 7 
DPI to resist JEV seemed also helpful to promote the first 
phase of viremia to turn to the second phase.  
T lymphocytes had the initial immune-depressed 
period in the first phase of viremia in which organism was 
in the preparation for resistance to alien JEV. T 
lymphocytes decreased in the first three days in challenge 
group. The balance between cells and JEV interactions 
determines the outcome of the viral infection and disease 
progression (Pastorino et al., 2010). It may need about 
three days for the rebuilding of proper immunity balance 
after the immunity break in response to JEV-infection, 
which may be ascribed to the relative low increase of T 
lymphocytes compared to the high increase of JEV 
virulent strain with the incubation amount of 6.25×10
3 
PFU.  
The distinct reduction of splenic T lymphocytes from 
8 to 10 DPI may be caused by T lymphocytes damage in 
spleen and its transfer to blood or brain. It indicates that 
the cellular immunity was not just out of existence in the 
second phase, but mainly transferred to other organs such 
as brain, the JEV target organ. The damage of T 
lymphocytes might have been caused by the cell apoptosis 
or death in the first and second phase of viremia. The 
examination of apoptosis of T lymphocytes and other cells 
in spleen under the influence of JEV is under investigation 
and will be reported later. T lymphocytes are usually 
transferred to brain out of spleen through blood 
circulation to provide immune surveillance and this may 
be hastened by neuro-inflammation. T lymphocytes injury 
in neuro-inflammation after entry into brain may 
accelerate T lymphocytes loss in the spleen, and may also 
cut off its return back to spleen as the normal T 
lymphocytes recirculation. This process consists of two 
steps as follows: 
In the first step, neuro-inflammation was activated 
after JEV entered the brain. Non-suppurative encephalitis 
areas in JEV-infected mice showed inflammatory cell 
infiltration and edema, with a predominance of activated Pak Vet J, 2011, 31(4): 299-304. 
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T lymphocytes, macrophages and B lymphocytes (Gould 
et al., 2008). Increased astrocyte activation was shown in 
our model, which implicates the enhanced ability to 
detoxify glutamate, inactivate free radicals, and produce 
neurotrophic factors, although it is not sufficient in 
conferring protection against JEV-mediated pathogenesis 
(Mishra et al., 2007). It was also shown in our model that 
microglia cells were activated in response to JEV 
infection. However, it was verified that uncontrolled 
overactivation  of  microglia  cells (Ghoshal  et  al.,  2007) 
releases pro-inflammatory cytokines such as interleukin 6 
 
 
 
 
 
 
 
Fig. 2: Histology of brain in control group and pathological changes 
after JEV infection. (A) Microglia activation, IBA antibody, IHC, 400×, 
light microscope, arrows show activated microglia; (B) Glial nodule near 
vessel, H & E, 400×, light  microscope, arrow show glial nodule near 
vessel; (C) Vessel in the control, H & E, 400×, light microscope, arrow 
show normal vessel without glial nodule around. 
 
 
 
 
 
 
 
 
Fig. 3: T lymphocytes in challenge group dropped at 8 DPI and 10DPI. 
(A) 8 DPI, spleen IHC-infected; (B) 8 DPI, spleen IHC-control; (C) 10 
DPI, spleen IHC-infected; (D) 10 DPI, spleen IHC-control. (A-D): CD3 
antibody, IHC, 40×. Arrows show PALS (periarterial lymphatic sheath), 
T lymphocytes were all around PALS.  Pak Vet J, 2011, 31(4): 299-304. 
 
303
Control group
Challenge group
 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
02468 1 0
O
D **
**
 
Experimental Days 
 
Fig. 4: The growth and decline trend of lymphocytes after JEV 
infected. OD: optical density of CD3 positive area; ** stands for 
highly significant difference (** P<0.01). 
 
(IL-6), TNF-a monocyte chemotactic protein 1 (MCP1), 
and RANTES (regulated upon activation, normal T 
lymphocytes expressed and secreted), promoting massive 
leukocyte migration and infiltration into the brain in 
Japanese encephalitis (Gupta et al., 2010).  
In the second step, T lymphocytes transferred into 
brain to provide immune surveillance and protect JEV-
infected mice from death after neuro-inflammation was 
activated. Nevertheless, if cellular immunity is not strong 
enough, the entrance of T lymphocytes into brain can also 
aggravate the neuro-inflammation and result in JEV 
hidding in the T lymphocytes (Mathur et al., 1989). T 
lymphocytes entry into the brain has been demonstrated 
by many studies. For instance, Fujii et al. (2008) found 
that the high infiltration of T lymphocytes in the brain of 
mice infected with JEV. T lymphocytes entry into the 
brain for immune surveillance is not only reported in 
Japanese encephalitis but also in West Nile Fever and tick 
borne encephalitis caused by West Nile virus and tick-
borne encephalitis virus which also belong to flavividae 
family (Sitati et al., 2007). Wang et al. (2003) proposed 
that CD8+ T lymphocytes mediated West Nile virus 
encephalitis recovery and it was also reported that the 
response of CD4
+ T lymphocytes was necessary for the 
CNS to remove West Nile virus (Sitati and Diamond, 
2006). In tick borne encephalitis, it was reported that 
CD8
+ T lymphocytes could extend the survival of tick-
borne encephalitis infected severe combined immune-
deficiency (SCID) mice or CD8
+ deficient mice. It was 
also confirmed that CD8
+ T lymphocytes were involved in 
immunopathogenesis of tick-borne encephalitis (Růžek et 
al., 2009).  
The sixth day post-infection on which neurological 
symptoms appeared was the critical turning point from the 
first phase of viremia to the second phase of viremia after 
JEV infection. Once JEV breakthrough the blood brain 
barrier (BBB), the neurons began to be under threat and 
perhaps the microglia cells and astrocytes were on their 
initiation of activation. At 6 DPI, the increase of 
lymphocytes was observed in JEV-infected mice, so 6 
DPI may be the time point when cellular immunity 
strengthened. Since cellular immunity was failed to 
combat against ectogenic pathogeny JEV in spleen during 
the first phase of viremia, on this time point, some splenic 
T lymphocytes suffered damage and some began to 
migrate to brain, which was induced by neuro-
inflammation. Therefore, cellular immunity was activated 
to resist the JEV infection when neurological dysfunction 
appeared.  
In conclusion, mice pathological model with JEV 
infection was successfully constructed in our study. 
Spleen as the biggest immune organ suffered irreversible 
damage in influence of JEV. The quantity of T 
lymphocytes changed and took on some regular trends 
which represent the strength of cellular immunity in 
resistance to JEV infection. Our results demonstrated that 
the cellular immunity took the crucial part in the first 
phase of viremia against JEV. Nevertheless, it needed 
about three days for cellular immune preparation for 
resistance to ectogenic JEV. Therefore, cellular immunity 
had the initial immune-depressed period in the first phase 
of viremia. Then the immune response was activated after 
the immune-depressed period and neurological 
dysfunction appeared when cellular immunity was 
activated. In addition, T lymphocytes were damaged in 
spleen and transferred to brain in the second phase of 
viremia. This may be strongly beneficial for the mice 
survival after CNS infection. In a word, our research 
showed the elaborate immunopathology changes of host 
with JEV infection, which may provide some clues for 
understanding the mechanism of Japanese encephalitis 
pathogenesis.  
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